Cingulate shares plans to resubmit its ADHD candidate CTx-1301 to the FDA, following a CRL tied to CMC information requests
|Poll|November 2, 2018
Mini Quiz: Measuring Sleep Quality in Patients With ADHD
Author(s)Margaret D. Weiss, MD, PhD
Which tool is useful to measure night-to-night variability, sleep onset latency, and sleep duration in those with ADHD?
Advertisement
Which of the following is a useful measure that can be used to visually display night-to-night variability, sleep onset latency, and sleep duration in those with ADHD?
Advertisement
Related to this article
Phase 2 trial shows daridorexant boosts pediatric insomnia sleep time up to 50 minutes, including ADHD/ASD patients, with strong safety and phase 3 plans.
Sleep disruption fuels Alzheimer risk via apnea, fragmentation, and inflammation; improving consolidated sleep, medication review, and sleep-specialist teamwork may protect cognition.
Advertisement
Advertisement
Trending on Psychiatric Times
1
NDA Submission Complete: COMP360 Psilocybin for Treatment-Resistant Depression
2
Lumateperone Shows Significant and Rapid Improvement in Bipolar Mania
3
Schizophrenia: A Telltale of the Brain’s Complexity
4
Promoting Literacy to Improve Child Development: Reading Model Boosts Efforts
5